Serum Anti-PDLIM1 Autoantibody as Diagnostic Marker in Ovarian Cancer

Serum Anti-PDLIM1 Autoantibody as Diagnostic Marker in Ovarian Cancer

BackgroundSerum autoantibodies (AAbs) against tumor-associated antigens (TAAs) could be useful biomarkers for cancer detection. This study aims to evaluate the diagnostic value of autoantibody against PDLIM1 for improving the detection of ovarian cancer (OC).MethodsImmunohistochemistry (IHC) test in...

Full description

Bibliographic Details
Main Authors: Cuipeng Qiu, Yaru Duan, Bofei Wang, Jianxiang Shi, Peng Wang, Hua Ye, Liping Dai, Jianying Zhang, Xiao Wang
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-08-01
Series:Frontiers in Immunology
Subjects:
autoantibody
tumor-associated antigens
ovarian cancer
PDLIM1
diagnostic marker
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2021.698312/full

Internet

https://www.frontiersin.org/articles/10.3389/fimmu.2021.698312/full

Similar Items